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Abstract: Pluripotent embryonic stem can (ES) cells can differentiateinto all cell lineages. During the process of embry-
onic development, ES cells are exposed to fluid flow or blood flow generated by the contracting heart. Absence of fluid 
flow results in the formation of abnormal cardiac chambers and valve formation. Thus, hemodynamic forces and ES cell 
differentiation to vascular progenitor cells (VPCs) are of emerging interests for restoring endothelial dysfunction, induc-
ing angiogenesis, and forming blood vessel networks. Hemodynamic forces such as fluid shear stress increase the percent-
age of cells in the S and G2-M phases, and induce decondensation of chromatin for gene transcription. Fluid shear stress 
further accelerates ES commitment to CD31
+ VPC vascular progenitor cells. These ES-derived CD31
+ cells express endo-
thelial nitric oxide synthase (eNOS) and von Willebrand factor (vWF). They are also capable of LDL uptake and tubular 
network formation. In this context, understanding hemodynamic forces and ES cell kinetics of differentiation towards en-
dothelial lineage has potential therapeutic applications for repairing vascular damage and engineering vascular graft.
Multidisciplinary team approach will likely garner momentum and synergize expertise to address the current road blocks 
in basic stem cell research for engraftable, restorative, low immunogenic, and non-tumorigenic endothelial progenitors in 
high purity and stability. 
INTRODUCTION 
  Life is regenerative. But by and large, humans lack the 
regenerative capacity of creatures such as newts and hydra. 
Emerging interest in using endothelial cells for therapeutic 
purposes has led to assessing hemodynamic forces as biome-
chanical stimuli for enriching embryonic stem (ES) cell 
commitment to endothelial progenitor cells. Endothelial cells 
(ECs) are critical cellular components of blood vessels. The 
denudation of the intact endothelial monolayer can cause 
lipid accumulation, monocyte adhesion, and inflammatory 
responses that initiate atherogenesis [1]. Pluripotent ES cells 
are capable of differentiating into all cell including neurons, 
cardiomyocytes, hematopoeitic cells, endothelial cells, os-
teogenic cells, and chondrocytes (Fig. 1) [2-5].  
BIOMECHANICAL FORCES AND VASCULAR   
BIOLOGY 
  Vascular endothelial cells in the resistant arteries are con-
stantly exposed to the dynamic changes of blood flow (Fig.
2). The hemodynamic forces can be resolved into three com-
ponents: (1) shear stress, the tangential frictional forceacting 
at the endothelial cell surface, (2) hydrostatic pressure, the 
perpendicular force acting on the vascular wall, and (3) cy-
clic strain, the circumferential stretch of vessel wall [6].  
  In response to biomechanical forces, namely, circumfer-
ential stretch of arterial wall and fluid shear stress, vascular
ECs undergo elongation in morphology in alignment with 
the direction of blood flow. In response to shear stress, ECs 
respond metabolically by altering the pro duction of vaso- 
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dilating substances, including nitric oxide, prostacyclin, C-
type natriuretic peptide, and adrenomedulin [8]. These fluid 
flow-induced phenotypic changes in EC function are often 
accompanied by genotypic changes in the expression of re-
lated genes [9].  
  Shear stress imparts metabolic as well as mechanical 
effects on vascular endothelial function, and is intimately 
involved in angiogenesis and atherosclerosis [1, 8, 11]. Dur-
ing atherosclerosis, disturbed flow, including oscillatory 
flow (bidirectional net zero forward flow), is considered to 
be an atherogenic hemodynamics, developing at the lateral 
wall (Fig. 3). By comparison, pulsatile flow is atheroprotec-
tive, developing at the medial wall of bifurcation or straight 
segments, and is responsible for down-regulating adhesion 
molecules, inflammatory cytokines, and oxidative stress [12-
14].  
STEM CELL, FLUID FLOW, AND VASCULOGENE-
SIS
  ES cell lines established from theinner cell mass of blas-
tocysts have the potential to differentiate into all embryonic 
cell lineages (Fig. 1) [15]. Developmentally, hemodynamic 
forces play an important role during myocardiogenesis. In-
tracardial fluid shear stress is an essential epigenetic factor 
for zebra fish embryonic cardiogenesis, and absence of fluid 
flow results in the formation of an abnormal cardiac cham-
bers and valve formation [16]. Disturbed flow is also a criti-
cal stimulus for morphologic embryonic heart. The direction 
of fluid flow on the node of mouse embryos determines the 
left-right asymmetryin the body plan [17]. 
  Fluid flow also influences the differentiation of ES cells 
[18, 19] and mesenchymal progenitors [20] to vascular endo-
thelial cells. Yamamoto et al. reported that fluid flow af-
fected differentiation of human bone marrow-derived endo-270 Current Cardiology Reviews, 2008, Vol. 4, No. 4 Hsiai and Wu 
thelial progenitor cells (EPCs) to ECs [21]. The molecular 
mechanisms by which hemodynamic forces regulate ES cell 
differentiation to vascular progenitor cells are an intense area 
of research for restoring endothelial dysfunction, inducing 
angiogenesis, and forming blood vessel networks.  
IN VITRO MODEL TO STUDY STEM CELL DIFFER-
ENTIATIONS  
  Developing new scale-up and cell separation technolo-
gies is critical to address the road blocks in basic stem cell 
Fig. (1). Development of vascular cells from human embryonic stem cells. Hemangioblasts are bipotential precursors to hematopoietic pro-
genitor cells and endothelial progenitor cells (EPCs). The origins of smooth muscle cells (SMCs) are dependent on the location in the em-
bryo. Vascular progenitor cells (VPCs) can further differentiate to mural cells (SMCs and pericytes) and endothelial cells. EPCs may trans-
differentiate into SMCs during vessel formation. ES cells express Oct3/4, and Sox2; vascular progenitors express CD133, CD31, CD34, c-
kit, and Flk-1 (VEGFR-2 receptor); and endothelial progenitors express CD31, CD 34, VE-Cadherin, vWF, and eNOS. 
Fig. (2). Schematic diagram of hemodynamic forces acting on endothelial cells (EC) and smooth muscle cells (SMC) in the blood vessel 
wall. (a) Fluid shear stress, the tangential frictional force by virtue of blood viscosity, acts on ECs. (b) Cyclic strain exerts a circumferential 
stretch on arterial wall in response to cardiac contraction. Hydrostatic pressure acts perpendicularly on ECs. (c) ECs are constantly exposed 
to both biomechanical and biochemical stimuli, which modulate endothelial functional phenotype. The biochemical stimuli include hor-
mones, growth factors, cytokines, and bacterial products that can be delivered via the blood or via autocrine or paracrine mechanisms [7]. Hemodynamic Forces Regulate Embryonic Stem Cell  Current Cardiology Reviews, 2008, Vol. 4, No. 4    271
research for clinical applications. Hemodynamic forces en-
visage the application of fluid flow in engineering in vitro
production of differentiated cardiovascular cells. Using a 
modified cone-and-plate flow device, Blackman et al. simu-
lated pulsatile shear stress in the common carotid artery and 
oscillatory shear stress in the lateral wall or point of flow 
separation in the internal carotid artery (Figs. 4a and 4c)
[22]. Using the parallel plate flow system, Yamamoto et al.
subjected the ES cells to laminar shear stress (Figs. 4b and
4d) [21]. The cone-and-plate model facilitated the assess-
ment of embroid bodies (EBs) and bone marrow-derived 
endothelial progenitor cells in a confined volume [22]. The 
parallel-plate model elucidated new insights into the molecu-
lar mechanisms whereby variations in shear stress parame-
ters influenced the rate and yield of CD31
+ cells [21].  
  Numerous bioreactors have been developed in an attempt 
for isolation and purification of vascular progenitors. The 
precise control of local flow milieu has allowed for assessing 
bone marrow-derived EPCs homing onto the vascular endo-
thelial cells [21]. The incorporation of feedback control sys-
tem to regulate both biochemical and biomechanical parame-
ters have provided insights into new scale-up and cell separa-
tion technologies. However, the focus remains to enrich the 
yield and rate CD31
+ cell population that are capable of LDL 
uptake and tube-like formation in Matrigel [18, 21]. 
BONE MARROW-DERIVED HEMATOPOIETIC 
STEM CELLS 
  Bone marrow cells contribute to the pathogenesis of vas-
cular diseases in models of postangioplasty restenosis, graft 
vasculopathy, and hyperlipidemia-induced atherosclerosis 
[23]. It was suggested that bone marrow cells or hema-
topoietic stem cells (HSCs) may have the potential to give 
rise to vascular progenitor cells that home in on the damaged 
vessels and differentiate them into smooth muscle cells or 
endothelial cells [23]. During this process, incorporated bone 
marrow-derived EPCs are exposed to shear stress. Thus, 
fluid shear stress and local flow patterns may influence reen-
dothelialization via EPC homing, proliferation, and differen-
tiation. However, the yield of isolated EPCs remains low and 
the underlying mechanism remains unknown. 
EMBRYONIC STEM CELLS-DERIVED VASCULAR 
PROGENITOR CELLS
  Human ES cells have been isolated to form stable pluri-
potent cell lines that are capable of unlimited proliferation 
under specific culture conditions. Human ES cells aggregate 
into clusters of cells or embroid bodies (EBs) that differenti-
ate into multiple tissue lineages (Fig. 1) [24-26]. These cells 
also appear to be weakly immunogenic, expressing moderate 
amounts of major histocompatibility complex (MHC) class I 
without MHC class II protein [27]. Multiple markers have 
been used to characterize the vascular-endothelial differen-
tiation capabilities of human ES cells (Fig. 1). Expression of 
vascular endothelial cadherin (VE-cad), platelet endothelial 
cell adhesion molecule-1 (PECAM-1), CD34, and Flk-1 
(human part JDR, vascular endothelial growth factor recep-
tor 2) and the ability to take up Dil-labeled acetylated low-
density lipoprotein (Dil-Ac-LDL) have been used as markers 
for identifying endothelial precursors [28]. Mature ECs were 
identified by selective staining for von Willebrand factor 
(vWF), endothelial nitric oxide synthase (eNOS), and E-
selectin proteins [29, 30]. Current road blocks in vascular 
stem cell research remain to develop new scale-up and cell 
separation technologies to deliver vascular progenitor cell 
population in high purity and stability with full retention of 
function. 
ENGINEERING ES CELL DIFFERENTIATION TO 
VPCS 
  Two main approaches have been used for purifying pro-
genitor ECs from human ES cells under static in vitro condi-
tions: (1) supplementing feeder layers for specific cell-
surface molecules; and (2) selecting EBs for specific cell-
surface molecules. The former used endothelial progenitors 
derived from EBs, undifferentiated hESC’s grown on various 
feeder layers from bone marrow stromal cells (S17 cell line) 
or mouse yolk-sac ECs (C166 cell line) [29]. After 17 days, 
undifferentiated human ES cells differentiated into an early 
hematopoietic subpopulation of CD34
+CD31
-CD45
- cells, 
with 50% of the CD34
+ cells coexpressing PECAM-1 [29]. 
Under pituitary extract and vascular endothelial growth fac-
Fig. (3). Shear stress and atherosclerosis. (a) Pulsatile versus oscillatory flow profiles at the reattachment point and the medial wall of bifur-
cation. (b) Pulsatile flow (red) occurs at the medial wall, whereas oscillating flow occurs at the reattachment point (blue). (c) The reattach-
ment point is the site at which flow separation and disturbed flow occur. (d) Arterial angiogram shows plaque formation at the sites of flow 
separation. (e) CFD simulation. At the reattachment point, the mean shear stress is known to be near zero [10]. 272 Current Cardiology Reviews, 2008, Vol. 4, No. 4 Hsiai and Wu 
tor (VEGF), these cells became attached and spindled-
shaped, strongly expressing PECAM-1, VE-cad, and capable 
of Dil-Ac-LDL uptake. The latter approach is based on iso-
lating EBs by fluorescence-activated cell sorting (FACS) of 
PECAM-1
+ cells that express mature endothelial protein 
vWF in addition to expression of CD34, Flk-1, and VE-cad, 
and being capable of Dil-Ac-LDL uptake [31]. After 7 to 12 
days of differentiation, human EBs developed into adhesive 
and non-adhesive cells. Some adhesive cells were found to 
express PECAM-1 (50%) and VE-cad (11%), whereas CD45 
cells (a marker for hematopoeitic progenitor cells) were not 
capable of taking of Dil-Ac-LDL [32]. Seeding these cells on 
Matrigel and supplementing with large amount of VEGF (50 
g/mL) resulted in a typical tubelike arrangement of elon-
gated ECs within the matrix [33]. 
  Recently, a novel method was developed to induce selec-
tive differentiation of ES cells into both vascular endothelial 
cells and mural cells (pericytes and vascular smooth muscle 
cells) [34, 35]. In this method, undifferentiated ES cells were 
cultured on type IV collagen-coated dishes, and VEGF re-
ceptor 2 (VEGF-R2) and Flk-1-positive (Flk-1
+) cells were
purified by flow cytometry sorting. The addition of VEGF to
the cultures promoted endothelial differentiation, whereas 
mural cells were induced by platelet-derived growth factor 
(PDGF)-BB. The vascular cells derived from Flk1
+ cells or-
ganized into vessel-like structures in 3-D culture and con-
tributed to the developing vasculature in vivo [36]. Bai et al.
chose CD34 as a marker to isolate human ES cell-derived 
endothelial progenitor cells [37]. CD34
+ cells are not ex-
pressed in undifferentiated human ES cells that expressed 
VEGFR2 and CD133. CD34
+ population was increased to 
approximately 10% at around day 12-15 from human ES 
cells by changing the differentiation medium of the mouse 
embryonic fibroblast (MEF) feeder cells to a serum free-
medium in the presence of VEGF, FGF-2, and BMP-4 [31, 
38, 39]. The isolated CD34
+ progenitor cells by MACS col-
umn gave rise to cells with endothelial morphology and ex-
pressed endothelial cell markers CD31, VE-cad, and vWF in 
endothelial cell culture medium [38, 39]. Collaborative re-
search will likely advance the vascular biology community 
to engineer rapid isolation of pure and stable vascular pro-
genitors (CD31, VE-cad, and vWF cell population) with full 
retention of function. 
SHEAR STRESS AND ES CELL COMMITMENT TO 
VPCS 
  Proliferation and differentiation of ES cells are promoted 
not only by "chemical stimuli" such as VEGF, PDGF, and 
TGF- [34, 35, 40, 41], but also by fluid shear stress. Lami-
nar shear stress at 10 dyn/cm
2 activated transcription from 
VEGF-R2 promoter [42]. Furthermore, shear stress at 1.5 to 
10.0 dyn/cm
2 increased the cell density of mouse Flk-1
+ or 
VEGF-R2
+ cells [35]. Cell cycle analysis demonstrated that 
shear stress decreased a larger percentage of the cells in the 
G0 and G1 phase and increased the percentage of cells in the 
S and G2-M phases in comparison with Flk-1
+ ES cells cul-
tured under static conditions. Shear stress also increased the 
expression of the vascular endothelial cell-specific markers 
Flk-1, Flt-1, VE-cad, and PECAM-1, but it had no effect on 
expression of the mural cell marker smooth muscle -actin, 
Fig. (4). (a) Schematic diagram of the embryonic cells (ES) in a dynamic model. The cone-and-plate flow device was modified to optimize 
ES cells exposure to well-defined shear stress and confluent vascular progenitor monolayers were analyzed for endothelial cell markers. (b)
Schematic diagram of the modified parallel plate model that was mounted on an inverted microscope. Confluent ES monolayers were moni-
tored in response to specific shear stress patterns. (c) Representative hemodynamic flow profiles generated by the cone-and plate-system. 
Pulsatile shear stress is denoted in blue and oscillatory shear stress in red. (d) In the parallel-plate system, unidirectional laminar shear stress 
is denoted in dark blue, pulsatile shear stress at a high slew rate (/t) is denoted in red, low slew rate in green, and oscillatory shear stress 
in brown. Diagrams are not drawn to scale. Hemodynamic Forces Regulate Embryonic Stem Cell  Current Cardiology Reviews, 2008, Vol. 4, No. 4    273
blood cell marker CD3, or the epithelial cell marker keratin 
[18]. 
 Zheng  et al. reported that exposing ES cell-derived ECs 
(defined as stem cell antigen-1-positive or Sca-1+) to shear 
stress at 12 dyne/cm
2 for 4 days increased the proliferation 
by ~70% [43]. RT-PCR analysis revealed that withdrawal of 
LIF and culture on collagen IV-coated slides increased 
mRNA expression of PECAM-1 (CD31), prominin 1 
(CD133), VE-cad(CD144), Flt-1, and Flk-1 in Sca-l
+ pro-
genitor cells [43]. Moreover, shear stress was implicated in 
up-regulation of the transcription factor myocyte enhancer 
factor-2 (MEF-2C) in ES cells. MEF-2C is highly important 
for cardiovascular development. Formation of MEF-2C-
Smad4/CBP complexes was observed in shear stress-treated 
ES cells, recapitulating some events occurring during ES cell 
differentiation into cardiovascular precursors [42, 44, 45]. 
These findings indicate that shear stressselectively promotes 
the differentiation of Flk-1
+ ES cells into the endothelial cell 
lineage to form tubular network significantly faster than the 
staticcontrols [35].
SHEAR STRESS AND EPIGENETIC MODIFICATION 
OF HISTONES 
  During embryonal organogenesis, chromatin remodeling 
plays an important role in regulating differentiation [46]. 
Shear stress promotes decondensation of chromatin to allow 
gene transcription. Epigenetic modification of histones plays 
an important role in chromatin condensation/decondensation 
[42]. Histones can be acetylated, phosphorylated, and methy-
lated by distinct classes of enzymes, namely histone acetyl-
transferases (HATs), histone deacetylase (HADACs), and 
histone methyltransferases.  
  Shear stress regulates gene expression by inducing epi-
genetic modification of histones and influences cell differen-
tiation in mouse ES cells. Zeng et al. showed that laminar 
flow activated histone deacetylase 3 (HDAC3) through the 
Flk-1-PI3K-Akt pathway and that HDAC3-mediated p53 
deacetylation and p21 activation were crucial for shear stress 
and VEFG-induced EC differentiation [43]. Illi et al. found 
that histone H3 phphorylation on serine 10 (S10) occurred 
within 30 minutes of shear stress exposure at 10 dyn/cm
2
[42]. Hence, fluid shear stress plays an important role in en-
riching and accelerating ES-derived vascular progenitor 
cells.
VASCULAR PROGENITOR CELLS AND IMPLICA-
TION FOR CARDIOVASCULAR MEDICINE 
  ES cells are advantageous for cell transplantation to re-
pair damaged ischemic tissues and restore endothelial dys-
function by virtue of their high proliferation capacity and 
pluripotency. ES cells undergo spontaneous in vitro differen-
tiation, leading to the formation of cardiovascular precursors 
among other cell types [5, 29, 47]. This process normally 
occurs in several days. However, exposure to shear stress 
accelerates the onset of cell expressing cardiovascular mark-
ers that become detectable after 24 hour of flow exposure. 
However, challenges remain to address the restorative capac-
ity, survival, engraftment, and tumorigenicity of human ES 
cell-derived endothelial cells. While a vast majority of re-
search concerning EC differentiation from ES cells is de-
rived from experiments involving growth factors and hy-
poxia environment [42], novel applications of local biome-
chanical milieu has provided an entry point to engineer arti-
ficial vessels to repair damaged vessels and to form vessel 
networks.  
SUMMARY
  Generation of endothelial cells from human ES cells not 
only provides a ready cell resource for potential clinical ap-
plications, but also paves an excellent avenue to study vascu-
logenesis and angiongenesis events in the human system. 
The endothelial progenitors isolated from human ES cells 
have various phenotypes because of varying derivation pro-
tocols and the supplementation of growth factors; even more 
importantly, they were isolated at different stages of devel-
opment [29]. Critical questions remain to address the road 
blocks in basic stem cell research for clinical applications: 
(1) understanding the kinetics of ES cell differentiation into 
VPCs, (2) the molecular mechanisms whereby shear stress 
induce ES differentiation to VPCs, (3) stability and function 
of ES cell-derived VPCs in formation of durable blood ves-
sels. The recent California Institute for Regenerative Medi-
cine Tools and Technologies Awards (RFA08-02) have gar-
nered momentum to develop a scale-up and cell purification 
system that will interface delivery of purified progenitors 
with molecular imaging to track stem cell function in the 
injured tissue function. The recent NHLBI Progenitor Cell 
Biology Consortium Planning Awards (RFA-HL-08-012) 
has further synergized multi-disciplinary efforts to identify 
and characterize progenitor cell lineages, to direct the differ-
entiation of stem and progenitor cells to the desired cell 
fates, and to develop new strategies to address the unique 
challenges presented by the transplantation of these cells.  
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